CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy ...

CAMBRIDGE, Mass., February 14, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders ...

CAMBRIDGE, Mass., February 14, 2025--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular ...

CAMBRIDGE, Mass., February 10, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA ...

CAMBRIDGE, Mass., February 14, 2025--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, ...

The following is an excerpt from Jing Qian's interview with the South China Morning Post. Jing is the Co-Founder and Managing Director of the Center for China Analysis. What should we be watching for ...

Cohen, born July 1, 1930, may be the last active China scholar of his generation. He has spent nearly seven decades working on that relationship by vigorously debating law, trade, and human rights ...

He had spoken with European scholars and representatives from the Global South and they found China's statements inspiring, providing much-needed certainty in an uncertain world, and expressed ...

As a long-time China scholar, and as I watch the early days of the Trump presidency, I cannot help but be reminded of the Chinese Communist Party’s assertion in the 1970s that everything Mao said or ...